OBJECTIVES:African-Americans (AAs) have a high prevalence of hypertension and their blood pressure (BP) control on treatment still lags behind other groups. In 2004, NHLBI funded five projects that aimed to evaluate clinically feasible interventions to effect changes in medical care delivery leading to an increased proportion of AA patients with controlled BP. Three of the groups performed a pooled analysis of trial results to determine: 1) the magnitude of the combined intervention effect; and 2) how the pooled results could inform the methodology for future health-system level BP interventions. METHODS: Using a cluster randomized design, the trials enrolled AAs with uncontrolled hypertension to test interventions targeting a combination of patient and clinician behaviors. The 12-month Systolic BP (SBP) and Diastolic BP (DBP) effects of intervention or control cluster assignment were assessed using mixed effects longitudinal regression modeling. RESULTS:2,015 patients representing 352 clusters participated across the three trials. Pooled BP slopes followed a quadratic pattern, with an initial decline, followed by a rise toward baseline, and did not differ significantly between intervention and control clusters: SBP linear coefficient = -2.60±0.21 mmHg per month, p<0.001; quadratic coefficient = 0.167± 0.02 mmHg/month, p<0.001; group by time interaction group by time group x linear time coefficient=0.145 ± 0.293, p=0.622; group x quadratic time coefficient= -0.017 ± 0.026, p=0.525). RESULTS were similar for DBP. The individual sites did not have significant intervention effects when analyzed separately. CONCLUSION: Investigators planning behavioral trials to improve BP control in health systems serving AAs should plan for small effect sizes and employ a "run-in" period in which BP can be expected to improve in both experimental and control clusters.
RCT Entities:
OBJECTIVES: African-Americans (AAs) have a high prevalence of hypertension and their blood pressure (BP) control on treatment still lags behind other groups. In 2004, NHLBI funded five projects that aimed to evaluate clinically feasible interventions to effect changes in medical care delivery leading to an increased proportion of AA patients with controlled BP. Three of the groups performed a pooled analysis of trial results to determine: 1) the magnitude of the combined intervention effect; and 2) how the pooled results could inform the methodology for future health-system level BP interventions. METHODS: Using a cluster randomized design, the trials enrolled AAs with uncontrolled hypertension to test interventions targeting a combination of patient and clinician behaviors. The 12-month Systolic BP (SBP) and Diastolic BP (DBP) effects of intervention or control cluster assignment were assessed using mixed effects longitudinal regression modeling. RESULTS: 2,015 patients representing 352 clusters participated across the three trials. Pooled BP slopes followed a quadratic pattern, with an initial decline, followed by a rise toward baseline, and did not differ significantly between intervention and control clusters: SBP linear coefficient = -2.60±0.21 mmHg per month, p<0.001; quadratic coefficient = 0.167± 0.02 mmHg/month, p<0.001; group by time interaction group by time group x linear time coefficient=0.145 ± 0.293, p=0.622; group x quadratic time coefficient= -0.017 ± 0.026, p=0.525). RESULTS were similar for DBP. The individual sites did not have significant intervention effects when analyzed separately. CONCLUSION: Investigators planning behavioral trials to improve BP control in health systems serving AAs should plan for small effect sizes and employ a "run-in" period in which BP can be expected to improve in both experimental and control clusters.
Authors: Laura P Svetkey; Kathryn I Pollak; William S Yancy; Rowena J Dolor; Bryan C Batch; Greg Samsa; David B Matchar; Pao-Hwa Lin Journal: Hypertension Date: 2009-12 Impact factor: 10.190
Authors: Jeffrey A Cutler; Paul D Sorlie; Michael Wolz; Thomas Thom; Larry E Fields; Edward J Roccella Journal: Hypertension Date: 2008-10-13 Impact factor: 10.190
Authors: Gbenga Ogedegbe; William Chaplin; Antoinette Schoenthaler; David Statman; David Berger; Tabia Richardson; Erica Phillips; Jacqueline Spencer; John P Allegrante Journal: Am J Hypertens Date: 2008-07-24 Impact factor: 2.689
Authors: Penny H Feldman; Margaret V McDonald; Jennifer M Mongoven; Timothy R Peng; Linda M Gerber; Liliana E Pezzin Journal: Circ Cardiovasc Qual Outcomes Date: 2009-05
Authors: Gbenga Ogedegbe; Jonathan N Tobin; Senaida Fernandez; William Gerin; Marleny Diaz-Gloster; Andrea Cassells; Chamanara Khalida; Thomas Pickering; Antoinette Schoenthaler; Joseph Ravenell Journal: Circ Cardiovasc Qual Outcomes Date: 2009-05
Authors: Bonnie L Svarstad; Jane Morley Kotchen; Theresa I Shireman; Stephanie Y Crawford; Pamela A Palmer; Eva M Vivian; Roger L Brown Journal: Circ Cardiovasc Qual Outcomes Date: 2009-05
Authors: William C Cushman; Charles E Ford; Paula T Einhorn; Jackson T Wright; Richard A Preston; Barry R Davis; Jan N Basile; Paul K Whelton; Robert J Weiss; Arnaud Bastien; Donald L Courtney; Bruce P Hamilton; Kent Kirchner; Gail T Louis; Tamrat M Retta; Donald G Vidt Journal: J Clin Hypertens (Greenwich) Date: 2008-10 Impact factor: 3.738
Authors: Hayden B Bosworth; Maren K Olsen; Janet M Grubber; Alice M Neary; Melinda M Orr; Benjamin J Powers; Martha B Adams; Laura P Svetkey; Shelby D Reed; Yanhong Li; Rowena J Dolor; Eugene Z Oddone Journal: Ann Intern Med Date: 2009-11-17 Impact factor: 25.391
Authors: Karen O Moss; Carolyn H Still; Lenette M Jones; Gabrielle Blackshire; Kathy D Wright Journal: West J Nurs Res Date: 2018-06-28 Impact factor: 1.967
Authors: Ata Murat Kaynar; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Krissy K Moehling; Michael Susick; Veli Bakalov; Bruce R Pitt; Daniel J Bain; Ted M Ross; Sean G Saul; Mahlon Raymund; Richard K Zimmerman Journal: Hum Vaccin Immunother Date: 2016-01-11 Impact factor: 3.452
Authors: Stephanie L Fitzpatrick; Sherita Hill Golden; Kerry Stewart; June Sutherland; Sharie DeGross; Tina Brown; Nae-Yuh Wang; Jerilyn Allen; Lisa A Cooper; Felicia Hill-Briggs Journal: Diabetes Care Date: 2016-12 Impact factor: 19.112
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Ronald G Victor; Kathleen Lynch; Ning Li; Ciantel Blyler; Eric Muhammad; Joel Handler; Jeffrey Brettler; Mohamad Rashid; Brent Hsu; Davontae Foxx-Drew; Norma Moy; Anthony E Reid; Robert M Elashoff Journal: N Engl J Med Date: 2018-03-12 Impact factor: 91.245
Authors: Mary Patricia Nowalk; Chyongchiou J Lin; Valory N Pavlik; Anthony E Brown; Song Zhang; Krissy K Moehling; Jonathan M Raviotta; Jeannette E South-Paul; Mary Hawk; Edmund M Ricci; Donald B Middleton; Suchita A Patel; Faruque Ahmed; Richard K Zimmerman Journal: Vaccine Date: 2016-08-26 Impact factor: 3.641
Authors: Penny H Feldman; Margaret V McDonald; Yolanda Barrón; Linda M Gerber; Timothy R Peng Journal: J Comp Eff Res Date: 2016-03-07 Impact factor: 1.744
Authors: Chyongchiou J Lin; Mary Patricia Nowalk; Valory N Pavlik; Anthony E Brown; Song Zhang; Jonathan M Raviotta; Krissy K Moehling; Mary Hawk; Edmund M Ricci; Donald B Middleton; Suchita Patel; Jeannette E South-Paul; Richard K Zimmerman Journal: BMC Infect Dis Date: 2016-11-03 Impact factor: 3.090
Authors: Robert B Hanlin; Irfan M Asif; Gregory Wozniak; Susan E Sutherland; Bijal Shah; Jianing Yang; Robert A Davis; Sean T Bryan; Michael Rakotz; Brent M Egan Journal: J Clin Hypertens (Greenwich) Date: 2018-01-05 Impact factor: 3.738